Current through Register Vol. 48, No. 9, September 27, 2024
Except as provided in
RHA 4.23, the licensee shall
require the authorized nuclear pharmacist to be a pharmacist who--
4.22.1 Is certified by a specialty board
whose certification process has been recognized by the Nuclear Regulatory
Commission or an Agreement State. The names of board certifications that have
been recognized by the Nuclear Regulatory Commission or an Agreement State are
posted on the NRC's Medical Uses Licensee Toolkit webpage. To have its
certification process recognized, a specialty board shall require all
candidates for certification to:
4.22.1.1
Have graduated from a pharmacy program accredited by the Accreditation Council
for Pharmacy Education (ACPE) or have passed the Foreign Pharmacy Graduate
Examination Committee (FPGEC) examination.
4.22.1.2 Hold a current, active license to
practice pharmacy;
4.22.1.3 Provide
evidence of having acquired at least 4000 hours of training/experience in
nuclear pharmacy practice. Academic training may be substituted for no more
than 2000 hours of the required training and experience; and
4.22.1.4 Pass an examination in nuclear
pharmacy administered by diplomats of the specialty board, that assesses
knowledge and competency in procurement, compounding, quality assurance,
dispensing, distribution, health and safety, radiation safety, provision of
information and consultation, monitoring patient outcomes, research and
development; or
4.22.2
Has completed 700 hours in a structured educational program consisting of both:
4.22.2.1 200 hours of classroom and
laboratory training in the following areas--
4.22.2.1.1 Radiation physics and
instrumentation;
4.22.2.1.2
Radiation protection;
4.22.2.1.3
Mathematics pertaining to the use and measurement of radioactivity;
4.22.2.1.4 Chemistry of radioactive material
for medical use; and
4.22.2.1.5
Radiation biology; and
4.22.2.2 Supervised practical experience in a
nuclear pharmacy involving--
4.22.2.2.1
Shipping, receiving, and performing related radiation surveys;
4.22.2.2.2 Using and performing checks for
proper operation of instruments used to determine the activity of dosages,
survey meters, and, if appropriate, instruments used to measure alpha- or
beta-emitting radionuclides;
4.22.2.2.3 Calculating, assaying, and safely
preparing dosages for patients or human research subjects;
4.22.2.2.4 Using administrative controls to
avoid medical events in the administration of radioactive material; and
4.22.2.2.5 Using procedures to
prevent or minimize radioactive contamination and using proper decontamination
procedures; and
4.22.3 Has obtained written attestation
signed by a preceptor authorized nuclear pharmacist, that the individual has
satisfactorily completed the requirements in
RHA 4.22.2 of this section
and is able to independently fulfill the radiation safety-related duties as an
authorized nuclear pharmacist.
